Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol

J. J. Kang, Y. W. Cheng, F. N. Ko, M. L. Kuo, C. N. Lin, C. M. Teng

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

1 Effects of xanthone and its derivative, 1,3,6,7-tetrahydroxyxanthone (norathyriol), on Ca2+ release and ryanodine binding were studied in isolated sarcoplasmic reticulum (SR) vesicles from rabbit skeletal muscle. 2 Both xanthone and norathyriol dose-dependently induced Ca2+ release from the actively loaded SR vesicles which was blocked by ruthenium red, a specific Ca2+ release inhibitor, and Mg2+. 3 Xanthone and norathyriol also dose-dependently increased apparent [3H]-ryanodine binding. Norathyriol, but not xanthone, produced a synergistic effect on binding activation when added concurrently with caffeine. 4 In the presence of Mg2+, which inhibits ryanodine binding, both caffeine and norathyriol, but not xanthone, could restore the binding to the level observed in the absence of Mg2+. 5 Xanthone activated the Ca2+-ATPase activity of isolated SR vesicles dose-dependently reaching 70% activation at 300 μM. 6 When tested in mouse diaphragm, norathyriol potentiated the muscle contraction followed by twitch depression and contracture in either a Ca2+-free bathing solution or one containing 2.5 mM Ca2+. These norathyriol-induced effects on muscle were inhibited by pretreatment with ruthenium red or ryanodine. 7 These data suggest that xanthone and norathyriol can induce Ca2+ release from the SR of skeletal muscle through a direct interaction with the Ca2+ release channel, also known as the ryanodine receptor.

Original languageEnglish
Pages (from-to)1736-1742
Number of pages7
JournalBritish Journal of Pharmacology
Volume118
Issue number7
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Sarcoplasmic Reticulum
Skeletal Muscle
Calcium
Ryanodine
Ruthenium Red
Caffeine
Xanthones
Ryanodine Receptor Calcium Release Channel
Calcium-Transporting ATPases
norathyriol
xanthone
Contracture
Muscle Contraction
Diaphragm
Rabbits
Muscles

Keywords

  • Calcium release
  • Ryanodine receptor
  • Skeletal muscle
  • Xanthones

ASJC Scopus subject areas

  • Pharmacology

Cite this

Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol. / Kang, J. J.; Cheng, Y. W.; Ko, F. N.; Kuo, M. L.; Lin, C. N.; Teng, C. M.

In: British Journal of Pharmacology, Vol. 118, No. 7, 1996, p. 1736-1742.

Research output: Contribution to journalArticle

Kang, J. J. ; Cheng, Y. W. ; Ko, F. N. ; Kuo, M. L. ; Lin, C. N. ; Teng, C. M. / Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol. In: British Journal of Pharmacology. 1996 ; Vol. 118, No. 7. pp. 1736-1742.
@article{4098f42681c54aec9be54b511906a166,
title = "Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol",
abstract = "1 Effects of xanthone and its derivative, 1,3,6,7-tetrahydroxyxanthone (norathyriol), on Ca2+ release and ryanodine binding were studied in isolated sarcoplasmic reticulum (SR) vesicles from rabbit skeletal muscle. 2 Both xanthone and norathyriol dose-dependently induced Ca2+ release from the actively loaded SR vesicles which was blocked by ruthenium red, a specific Ca2+ release inhibitor, and Mg2+. 3 Xanthone and norathyriol also dose-dependently increased apparent [3H]-ryanodine binding. Norathyriol, but not xanthone, produced a synergistic effect on binding activation when added concurrently with caffeine. 4 In the presence of Mg2+, which inhibits ryanodine binding, both caffeine and norathyriol, but not xanthone, could restore the binding to the level observed in the absence of Mg2+. 5 Xanthone activated the Ca2+-ATPase activity of isolated SR vesicles dose-dependently reaching 70{\%} activation at 300 μM. 6 When tested in mouse diaphragm, norathyriol potentiated the muscle contraction followed by twitch depression and contracture in either a Ca2+-free bathing solution or one containing 2.5 mM Ca2+. These norathyriol-induced effects on muscle were inhibited by pretreatment with ruthenium red or ryanodine. 7 These data suggest that xanthone and norathyriol can induce Ca2+ release from the SR of skeletal muscle through a direct interaction with the Ca2+ release channel, also known as the ryanodine receptor.",
keywords = "Calcium release, Ryanodine receptor, Skeletal muscle, Xanthones",
author = "Kang, {J. J.} and Cheng, {Y. W.} and Ko, {F. N.} and Kuo, {M. L.} and Lin, {C. N.} and Teng, {C. M.}",
year = "1996",
language = "English",
volume = "118",
pages = "1736--1742",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Induction of calcium release from sarcoplasmic reticulum of skeletal muscle by xanthone and norathyriol

AU - Kang, J. J.

AU - Cheng, Y. W.

AU - Ko, F. N.

AU - Kuo, M. L.

AU - Lin, C. N.

AU - Teng, C. M.

PY - 1996

Y1 - 1996

N2 - 1 Effects of xanthone and its derivative, 1,3,6,7-tetrahydroxyxanthone (norathyriol), on Ca2+ release and ryanodine binding were studied in isolated sarcoplasmic reticulum (SR) vesicles from rabbit skeletal muscle. 2 Both xanthone and norathyriol dose-dependently induced Ca2+ release from the actively loaded SR vesicles which was blocked by ruthenium red, a specific Ca2+ release inhibitor, and Mg2+. 3 Xanthone and norathyriol also dose-dependently increased apparent [3H]-ryanodine binding. Norathyriol, but not xanthone, produced a synergistic effect on binding activation when added concurrently with caffeine. 4 In the presence of Mg2+, which inhibits ryanodine binding, both caffeine and norathyriol, but not xanthone, could restore the binding to the level observed in the absence of Mg2+. 5 Xanthone activated the Ca2+-ATPase activity of isolated SR vesicles dose-dependently reaching 70% activation at 300 μM. 6 When tested in mouse diaphragm, norathyriol potentiated the muscle contraction followed by twitch depression and contracture in either a Ca2+-free bathing solution or one containing 2.5 mM Ca2+. These norathyriol-induced effects on muscle were inhibited by pretreatment with ruthenium red or ryanodine. 7 These data suggest that xanthone and norathyriol can induce Ca2+ release from the SR of skeletal muscle through a direct interaction with the Ca2+ release channel, also known as the ryanodine receptor.

AB - 1 Effects of xanthone and its derivative, 1,3,6,7-tetrahydroxyxanthone (norathyriol), on Ca2+ release and ryanodine binding were studied in isolated sarcoplasmic reticulum (SR) vesicles from rabbit skeletal muscle. 2 Both xanthone and norathyriol dose-dependently induced Ca2+ release from the actively loaded SR vesicles which was blocked by ruthenium red, a specific Ca2+ release inhibitor, and Mg2+. 3 Xanthone and norathyriol also dose-dependently increased apparent [3H]-ryanodine binding. Norathyriol, but not xanthone, produced a synergistic effect on binding activation when added concurrently with caffeine. 4 In the presence of Mg2+, which inhibits ryanodine binding, both caffeine and norathyriol, but not xanthone, could restore the binding to the level observed in the absence of Mg2+. 5 Xanthone activated the Ca2+-ATPase activity of isolated SR vesicles dose-dependently reaching 70% activation at 300 μM. 6 When tested in mouse diaphragm, norathyriol potentiated the muscle contraction followed by twitch depression and contracture in either a Ca2+-free bathing solution or one containing 2.5 mM Ca2+. These norathyriol-induced effects on muscle were inhibited by pretreatment with ruthenium red or ryanodine. 7 These data suggest that xanthone and norathyriol can induce Ca2+ release from the SR of skeletal muscle through a direct interaction with the Ca2+ release channel, also known as the ryanodine receptor.

KW - Calcium release

KW - Ryanodine receptor

KW - Skeletal muscle

KW - Xanthones

UR - http://www.scopus.com/inward/record.url?scp=0029998211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029998211&partnerID=8YFLogxK

M3 - Article

C2 - 8842439

AN - SCOPUS:0029998211

VL - 118

SP - 1736

EP - 1742

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -